| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.28 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |